Hematology Oncology Recent Publications | Texas Tech University Health Sciences Center

Hematology Oncology Recent Publications

FACULTY PUBLICATIONS

  • CHRONIC MYELOGENOUS LEUKEMIA BCR/ABL POSITIVE COMPLICATING A PREGNANCY AUTHORS (LAST NAME, FIRST NAME): Juarez Ramirez Tello, Edna Maritza 1; Sultan, Anita 1; Khan, Saad 3; Tijani, Lukman. Abstract accepted for presentation at Southern Society for Clinical Investigation Annual Meeting (2017)
  • Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs) Kyaw Zin Thein, Lukman Tijani and Thein H. Oo. Blood 2016 128:1180; An oral presentation at the Annual ASH meeting in December, 2016.
  • Differential Modulation of Glutathione Metabolism in Adeno and Squamous NSCLC by 2HF: Tijani L, Awasthi S. A Poster Presentation at the IASLC 2016, Multidisciplinary Symposium in Thoracic Oncology September, 2016.
  • Figarola J, Singhal J, Tompkins J, Rogers G, Warden C, Horne D, Riggs , Awasthi S, and Singhal SS. (2015) SR4 uncouples mitochondrial oxidative-phosphorylation, modulates AMPK-mTOR signaling, and inhibits proliferation of HepG2 hepatocarcinoma cells. J Biol Chem 290: 30321-30341(PMID: 26534958).
  • Yadav S, Singhal J, Eroglu Z, Berz D, Singhal SS, Awasthi YC, and Awasthi S. (2016) Simultaneous targeting of multiple survival pathways in breast cancer.
  • Suarez, M.G. MD; Sultan A. MD; Verma R. MD; Hardwicke F. MD. Can elevated coagulation factor VIII cause thrombosis? Journal of Investigative Medicine. 2016, Feb; 64(2): 707-708.
    Sultan, A. MD; Ibilibor C. MD; Suarez M. MD; Shanshal M. MD; Hardwicke F. MD. Small cell cancer with a rare presentation as Bladder cancer. Journal of Investigative Medicine. 2016, Feb; 64(2): 562
  • Singhal SS, Singhal J, Figarola JL, Riggs A, Horne D, and Awasthi S. (2015) 2'-Hydroxyflavanone: A promising molecule for kidney cancer prevention. Biochem Pharmacol 96: 151-158 (PMID: 25957660).
  • Singhal, S.S., Figarola, J., Singhal, J., Rahbar, S., Awasthi, S., and Horne, D. (2015) Role of COH-SR4 in diabetes: glutathione-linked enzymes and oxidative stress. Endocrine Reviews 36: Abs # 27.
    Singhal SS, Singhal J, Figarola JL, Horne D, and Awasthi S. (2015) RLIP76 targeted therapy for kidney cancer. Pharm Res 32:3123–3136 (PMID: 26021465).
  • Singhal SS, Singh SP, Singhal P, Horne D, Singhal J, and Awasthi S. (2015) Antioxidant role of glutathione s-transferases: 4-hydroxynonenal, a key molecule in stress-mediated signaling. Toxicol Appl Pharmacol 289: 361-370 (PMID: 26476300).
  • Wurtzel JG, Lee S, Singhal SS, Awasthi S, Ginsberg MH, and Goldfinger LE. (2015) RLIP76 regulates Arf6-dependent cell spreading and migration by linking ARNO with activated R-Ras at recycling endosomes. Biochem Biophys Res Commun 467: 785-791(PMID: 26498519).
  • Figarola J, Singhal J, Tompkins J, Rogers G, Warden C, Horne D, Riggs , Awasthi S, and Singhal SS. (2015) SR4 uncouples mitochondrial oxidative-phosphorylation, modulates AMPK-mTOR signaling, and inhibits proliferation of HepG2 hepatocarcinoma cells. J Biol Chem 290: 30321-30341(PMID: 26534958).
  • Hosiriluck N, Klomjit S, Rassameehiran S, Sutamtewagul G, Tijani L, Radhi S. The Southwest Respiratory and Critical Care Chronicles. Volume 3, No9 (2015) Prognostic factors for mortality with febrile neutropenia in hospitalized patients.
  • Jose A. Figueroa, Adair Reidy, Nicholas D’Cunha, Luke N. D’Cunha, Everardo Cobos, Maurizio Chiriva-Internati et al. Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy: International Reviews of Immunology, 34:154–187, 2015.
  • R Verma, J Riaz, L Mirandola, J Figueroa, S Radhi, N. D’Cunha, et al. Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer. Abstract #132602 Submitted to American Society of Clinical Oncology June 2014
  • L Mirandola, J Riaz, R Verma, S Radhi, T Pham, A Aulakh, V Konala, N. D’Cunha et al. Cancer testis antigens: Potential new targets for lung cancer. Abstract Submitted to American Society of Clinical Oncology June 2014
  • Cobos C, Figueroa J, Mirandola, L, Colombo M, Summers G, Figueroa A, Aulakh, A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman R ,Pandey, A, Radhi S, Nguyen D, Jenkins M, Chiriva-Internati M, Cobos E May (2014) The Role of Human Papilloma Virus (HPV) Infection in Non-Anogenital Cancer and the Promise of Immunotherapy: A Review.
  • Panikkath R, Konala V, Panikkath D, Umyarova E, Hardwicke FL. Fatal Clostridium septicum infection in a patient with a hematological malignancy., 27(2): 111-2, April 2014. PubMed Central ID Number: 24688190
  • H. Maze, V. Konala, S. Omar, A. Mustafa, I. Warraich, N. D'Cunha. A Rare Case of Adult Alveolar Synovial habdomyosarcoma (SNRMS): Selected for poster presentation at the Southern Society for Clinical Investigation (SSCI), New Orleans, LA. Feb 2014
  • Panikkath R, Radhi S, Yik Lim S, Thankam M, Quattromani F, Jumper C. The Southwest Respiratory and Critical Care Chronicles. Volume 1 Issue 4 (2013) Metastasis of lung cancer through Batson’s plexus: very rare but possible.
  • N. Dumrongmongcolgul, C. Mankongpaisarnrung, G. Sutamtewagul, N. Hosiriluck, T. Chen, A. Trujillo, N. D’Cunha, K. Nugent, L. Ann Jenkins. Reactive Thrombocytosis Associated with Acute Myocardial Infarction Following STEMI with Percutaneous Coronary Intervention - A Case Report: Case Reports in Cardiology; Vol. 2013 (2013), Article ID 707438. http://dx.doi.org/10.1155/2013/707438
  • Charles Saadeh, Chad Wade, Jesse Mer, Saba Radhi, Raed Alalawi, Leonardo Mirandola, Yuefei Yu, Apurva Pandy, Diane Nguyen, Lukman Tijani, Nicholas D'Cunha, Fred Hardwicke, Marjorie Jenkins, Cynthia Jumper, Maurizio Chiriva-Internati, Everardo Cobos. The expressions of Sp17/AKAp4/PTTG1 in Non-small cell lung cancer detected both in serology and tissue student research week. 2013.
  • L. N. D'Cunha, N. C. D'Cunha, D. Harville, E. Cobos. Compare the Outcome of Patients with Hematological Malignancies Treated with Allogeneic Stem Cell Transplant in Patients Age over 50 Conditioned with Reduce Intensity Regimens with those under 50 Conditioned with Standard Intensity Regimen in a Rural University Hospital – A Single Institution Experience. Published online-on the December 2013 ASH abstracts site.  ttp://bloodjournal.hematologylibrary.org/site/misc/ash_meeting_abstracts_info.xhtml
  • Mast cells and the liver again process. Grizzi F, Di Crao G, Laghi L, Hermonat P, Mazzola P, Nguyen DD, Radhi S, Figueroa JA, Cobos E, Annoni G, Chiriva-Internati M. Immun Ageing. 2013 Mar 7;10(1):9.. PMID 23496863
  • Aging, cancer and cancer vaccines. Mazzola P, Radhi S. Mirandola L, Annoni G, Jenkins M, Cobos E, Chiriva-Internati M. Immun Ageing. 2012 April 17;9(1)4.. PMID 22510392 
  • Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma. Mirandola L, Yu Y, Chui K, Jenkins MR, Cobos E, John CM, Chiriva-Internati M. PLoS One. 2011;6(7):e21811. Epub 2011 Jul 13. PMID: 21765917 [PubMed - in process] Free PMC Article Free full text Related citations
  • Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy. Chiriva-Internati M, Mirandola L, Yu Y, Jenkins MR, Gornati R, Bernardini G, Gioia M, Chiaramonte R, Cannon MJ, Kast WM, Cobos E. J Immunother. 2011 Jul-Aug;34(6):490-9. PMID: 21654522 [PubMed - in process] Related citations
  • Notch-ing from T-cell to B-cell lymphoid malignancies. Mirandola L, Comi P, Cobos E, Kast WM, Chiriva-Internati M, Chiaramonte R. Cancer Lett. 2011 Sep 1;308(1):1-13. PMID: 21652011 [PubMed - in process] Related citations
  • Genistein inhibited proliferation and induced apoptosis in acute lymphoblastic leukemia, lymphoma and multiple myeloma cells in vitro. Li W, Frame LT, Hoo KA, Li Y, D'Cunha N, Cobos E. Leuk Lymphoma. 2011 Jul 13. [Epub ahead of print] PMID: 21749310 [PubMed - as supplied by publisher] Related citations
  • Sperm protein 17: clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond. Chiriva-Internati M. Int Rev Immunol. 2011 Apr-Jun;30(2-3):138-49. PMID: 21557640 [PubMed - in process] Related citations
  • Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. Mirandola L, J Cannon M, Cobos E, Bernardini G, Jenkins MR, Kast WM, Chiriva-Internati M. Int Rev Immunol. 2011 Apr-Jun;30(2-3):127-37. PMID: 21557639 [PubMed - in process] Related citations
  • Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment? Chiriva-Internati M, Cobos E, Cannon MJ. Int Rev Immunol. 2011 Apr-Jun;30(2-3):67-70. PMID: 21557634 [PubMed - in process] Related citations
  • Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies. Chiriva-Internati M, Mirandola L, Kast WM, Jenkins MR, Cobos E, Cannon MJ. Int Rev Immunol. 2011 Apr-Jun;30(2-3):71-86. PMID: 21557635 [PubMed - in process] Related citations
  • Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. Chiriva-Internati M, Yu Y, Mirandola L, D'Cunha N, Hardwicke F, Cannon MJ, Cobos E, Kast WM. Prostate. 2011 Apr 25. doi: 10.1002/pros.21400. [Epub ahead of print] PMID: 21520158 [PubMed - as supplied by publisher] Related citations
  • Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage? Cannon MJ, Goyne H, Stone PJ, Chiriva-Internati M. Expert Opin Biol Ther. 2011 Apr;11(4):441-5. Epub 2011 Jan 28. Review. PMID: 21271951 [PubMed - indexed for MEDLINE] Related citations
  • Nanotechnology and human health: risks and benefits. Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, Bernardini G. J Appl Toxicol. 2010 Nov;30(8):730-44. doi: 10.1002/jat.1609. Review. PMID: 21117037 [PubMed - indexed for MEDLINE] Related citations
  • Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression. Funel N, Costa F, Pettinari L, Taddeo A, Sala A, Chiriva-Internati M, Cobos E, Colombo G, Milzani A, Campani D, Dalle-Donne I, Gagliano N. Pancreatology. 2010;10(5):545-52. Epub 2010 Oct 23. PMID: 20975318 [PubMed - indexed for MEDLINE] Related citations
  • Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer. Chiriva-Internati M, Yu Y, Mirandola L, Jenkins MR, Chapman C, Cannon M, Cobos E, Kast WM. PLoS One. 2010 May 12;5(5):e10471. PMID: 20485677 [PubMed - indexed for MEDLINE] Free PMC Article Free full text Related citations
  • An update on hematological malignancies. D'Cunha N, Cobos E. Tex Med. 2010 Sep 1;106(9):59-63. PMID: 20809446 [PubMed - in process] Related citations
  • Daniele C, Ferguson M, Phillips C, Lachmansingh J, Nichols J, Fisher J, Holstead B, Opoku A. “Novel origin of cerebral phaeohyphomycosis: A case report.” The Southwest Respiratory and Critical Care Chronicles, 8(33), 52-55. (2020) https://doi.org/10.12746/swrccc.v8i33.637. 
  • Mantilla B, Vinan-Vega M, Solis X, Elmassry M, Nichols J, Nugent K.M. “Multiple Spontaneous Pneumothoraces in an Immunocompetent Patient with Cryptococcus.” American Journal of Respiratory and Critical Care Medicine, 2020; 201: A3954
  • Mantilla B, Medway A, Cooper C, Nugent K, Warraich I, Nichols J. Rare Case of Disseminated Coccidioidomycosis Presenting as a Renal Mass Mimicking Carcinoma. Urology. 2020 Nov;145:e4-e7. doi: 10.1016/j.urology.2020.08.013. Epub 2020 Aug 19. PMID: 32827533.
  • Castro-Piedras I, Vartak D, Sharma M, Pandey S, Casas L, Molehin D, Rasha F, Fokar M, Nichols J, Almodovar S, Rahman RL and Pruitt K (2020) Identification of Novel MeCP2 Cancer-Associated Target Genes and Post-Translational Modifications. Front. Oncol. 10:576362. doi: 10.3389/fonc.2020.576362
  • Gonzalez-Ortiz C, Emrick A, Tabak YP, Vankeepuram L, Kurtz S, Sellers D, Wimmer M, Asjes C, Suady Barake S, Nichols J, Levent F. Impact on Microbiology Laboratory Turnaround Times Following Process Improvements and Total Laboratory Automation. J Exp Pathol. 2021;2(1):16-25.
  • Evans N, Martinez E, Petrosillo N, Nichols J, Islam E, Pruitt K, Almodovar S. SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack. HIV AIDS (Auckl). 2021;13:361-375 https://doi.org/10.2147/HIV.S300055
  • Evans N, Nichols J, Pruitt K and Almodovar S. (2021). “Lung Time No See”: SARS-Cov-2 Spike Protein Changes Genetic Expression in Human Primary Bronchial Epithelial Cells After Recovery. The FASEB Journal, 35: https://doi.org/10.1096/fasebj.2021.35.S1.03097
  • Crist CJ, Hosiriluck N, Winn RE.  Post-infectious encephalomyelitis in an orthopedic surgeon with motor and cognitive impairment following Campylobacter gastroenteritis with complete recovery.  The Southwest Respiratory and Critical Care Chronicles 2018;6(23):22-27.
  • Moussavi F, Nath S, Abraham D, Landman D, Quale J. In Vitro and In Vivo Activity of Single and Dual Antimicrobial Agents Against KPC-producing Klebsiella pneumoniae. Open Forum Infect Dis. 2017;4(Suppl 1):S379. Published 2017 Oct 4. doi:10.1093/ofid/ofx163.936 PMCID: PMC5630717
  • Nath S, Lazarte S. Interpreting CD4 Counts in a Patient With HIV. JAMA Intern Med. 2019;179(11):1578–1579. PMID: 31479108
  • Nath, S., Moussavi, F., Abraham, D., Landman, D., & Quale, J. In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy, 73(2), 431-436. PMID: 29186402
  • S Nath, S Kumar, F Liang, C Abrahim, N Shereen, J Green, M Ramirez, A Burza, P Geraghty. "An audit of supplemental oxygen prescribing practices in an inpatient setting and its financial burden.” ." (2018): PA3160.European Respiratory Journal 2018 52: PA3160; 

FELLOWS PUBLICATIONS

Abstracts accepted

  • 06/2018: Pulmonary Spindle Cell Neoplasm - Neoadjuvant treatment and response; Amr Ismail, Anita Sultan, Kyaw Z. Thein, Sriman Swarup, Kenneth Nugent, Lukman Tijani, Fred Hardwicke. Accepted to IASLC 19th World Conference on Lung Cancer, 2018.

  • 06/2018: Osimertinib-related hematological and pulmonary toxicities in advanced NSCLC patients: combined analysis of phase III trials; Sriman Swarup, Kyaw Z. Thein, Somedeb Ball, Miguel Quirch, Yuttiwat Vorakunthada, Anita Sultan, Fred Hardwicke, Lukman Tijani, Sanjay Awasthi. Accepted to IASLC 19th World Conference on Lung Cancer, 2018.

  • 06/2018: Risk of gastrointestinal and hepatic toxicities in patients with advanced non-small-cell lung cancer treated with osimertinib; Kyaw Z. Thein, Sriman Swarup, Somedeb Ball, Miguel Quirch, Yuttiwat Vorakunthada, Saad Khan, Fred Hardwicke, Sanjay Awasthi, Lukman Tijani. Accepted to IASLC 19th World Conference on Lung Cancer, 2018.

  • 06/2018: A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of hematological toxicities in patients with multiple myeloma treated with daratumumab; Myint A. Win, Kyaw Z. Thein, Ei M. Phyu, Myat M. Han, Nicholas D’Cunha, Lukman Tijani, Mark Currie, Donald Quick, Kenneth Pendergrast. Accepted to Society of Hematologic Oncology 2018 Annual Meeting.

  • 06/2018: Daratumumab-related pulmonary toxicities in patients with multiple myeloma: a systematic review and meta-analysis of phase III randomized controlled trials; Myint A. Win, Kyaw Z. Thein, Ei M. Phyu, Myat M. Han, Paul D’Cunha, Joseph Nelson III, Donald Quick, Allan Sklar. Accepted to Society of Hematologic Oncology 2018 Annual Meeting.

  • 06/2018: Risk of gastrointestinal toxicities and health-related quality of life events in patients with multiple myeloma treated with daratumumab; Myint A. Win, Kyaw Z. Thein, Ei M. Phyu, Myat M. Han, Donald Quick, Prospero Cortorreal, Lukman Tijani, Edward Griffin. Accepted to Society of Hematologic Oncology 2018 Annual Meeting.

  • 05/2018: Updated meta-analysis of randomized controlled trials (RCTs) to determine the CDK 4/6 inhibitors associated venous thromboembolism (VTE) risk in hormone receptor-positive breast cancer (BC) patients; Kyaw Z. Thein, Somedeb Ball, Myo H. Zaw, Aung M. Tun, Miguel Quirch, Fred Hardwicke, Nicholas D’Cunha, Lukman Tijani, Catherine Jones, Thein H. Oo. Accepted to European Society for Medical Oncology 2018 Congress.

  • 05/2018: Risk of health-related quality of life events and pulmonary toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance. Kyaw Z. Thein, Anita Sultan, Myo H. Zaw, Myat M. Han, Nyein H. Yu, Henry P. Igid, Catherine Jones, Nicholas D’Cunha, Sanjay Awasthi, Fred Hardwicke. Accepted to European Society for Medical Oncology 2018 Congress

  • 05/2018: A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of gastrointestinal and hepatic toxicities in patients with recurrent ovarian cancer treated with poly adenosine diphosphate ribose polymerase inhibitors maintenance. Kyaw Z. Thein, Anita Sultan, Myo H. Zaw, Myat M. Han, Aung M. Hein, Htay H. Aung, Sanjay Awasthi, Catherine Jones, Fred Hardwicke, Nicholas D’Cunha. Accepted to European Society for Medical Oncology 2018 Congress.

  • 05/2018: Risk of secondary hematological malignancies and hematological toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance. Kyaw Z. Thein, Anita Sultan, Myo H. Zaw, Myat M. Han, Rachana Yendala, Myet M. Zin, Sanjay Awasthi, Nicholas D’Cunha, Fred Hardwicke, Catherine Jones. Accepted to European Society for Medical Oncology 2018 Congress.

  • 05/2018: Incidence of cardiac toxicities in patients with advanced non-small-cell lung cancer treated with osimertinib: a combined analysis of two phase III randomized controlled trials. Kyaw Z. Thein, Sriman Swarup, Somedeb Ball, Miguel Quirch, Yuttiwat Vorakunthada, Khaing K. Htwe, Nicholas D’Cunha, Fred Hardwicke, Sanjay Awasthi, Lukman Tijani. Accepted to European Society for Medical Oncology 2018 Congress

  • Suvorava N, Dobronski L, Mazek H, Nichols J, Winn R. “Pasteurella multocida cellulitis of the knee in a patient with recent total knee arthroplasty.” Journal of Investigative Medicine. 2014 Feb; 62(2): 437. Publication Status: Published.

     

  • Nichols J, Srisung W, Yarbrough S. "Round Pneumonia with Pseudomonas Luteola and Escherichia Vulneris." The Southwest Respiratory and Critical Care Chronicles 3(12), 15-17. (2015) https://pulmonarychronicles.com/index.php/pulmonarychronicles/article/view/228.

Abstracts published

  • 05/2018: Incidence of dermatological toxicities and fatigue in patients with cancer treated with regorafenib: A systematic review and meta- analysis of randomized controlled trials. Miguel Quirch, Kyaw Z. Thein, Saad Khan, Anita Sultan, Sriman Swarup, Lukman Tijani, Catherine Jones, Fred Hardwicke. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.10123.

  • 05/2018: Risk of gastrointestinal and hepatic toxicities in patients with cancer treated with regorafenib: A systematic review and meta- analysis of randomized controlled trials. Rachana Yendala, Kyaw Z. Thein, Anita Sultan, Sriman Swarup, Lukman Tijani, Fred Hardwicke, Catherine Jones. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e22118.

  • 05/2018: A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of hypophosphatemia, hypertension and hematological toxicities in patients with cancer treated with regorafenib. Henry P. Igid, Kyaw Z. Thein, Anita Sultan, Sriman Swarup, Sanjay Awasthi, Catherine Jones, Fred Hardwicke. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e22218.

  •  

    5/2018: Risk of gastrointestinal and hepatic toxicities in patients with advanced breast cancer treated with everolimus: a meta- analysis of phase 3 randomized controlled trials. Sriman Swarup, Kyaw Z. Thein, Anita Sultan, Saad Khan, Catherine Jones, Sanjay Awasthi, Fred Hardwicke. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e22215.

  • 05/2018: Risk of hematological toxicities in patients with advanced breast cancer treated with everolimus: a meta- analysis of phase 3 randomized controlled trials. Anita Sultan, Kyaw Z. Thein, Sriman Swarup, Nicholas D’Cunha, Fred Hardwicke, Catherine Jones, Sanjay Awasthi. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e13087.

  • 05/2018: A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of health-related quality of life and metabolic events in patients with advanced breast cancer treated with everolimus. Somedeb Ball, Kyaw Z. Thein, Saad Khan, Sriman Swarup, Anita Sultan, Fred Hardwicke, Nicholas D’Cunha, Catherine Jones . 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e22219. 

  • 05/2018: A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of pulmonary toxicities in patients with advanced breast cancer treated with everolimus. Sriman Swarup, Kyaw Z. Thein, Anita Sultan, Rachana Yendala, Sanjay Awasthi, Fred Hardwicke, Catherine Jones. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e13086.

  • 05/2018: Risk of hematological and gastrointestinal toxicities in patients with advanced neuroendocrine tumors treated with everolimus: a meta- analysis of phase 3 randomized controlled trials. Anita Sultan, Kyaw Z. Thein, Sriman Swarup, Somedeb Ball, Lukman Tijani, Sanjay Awasthi, Catherine Jones, Fred Hardwicke. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e16184.

  • 5/2018: Risk of health-related quality of life events and pulmonary toxicities in patients with advanced neuroendocrine tumors treated with everolimus: a meta- analysis of phase 3 randomized controlled trials. Kyaw Z. Thein, Anita Sultan, Sriman Swarup, Miguel Quirch, Lukman Tijani, Fred Hardwicke, Catherine Jones, Sanjay Awasthi. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e16185.

  • 05/2018: Risk of hematological, gastrointestinal and hepatic toxicities in patients with advanced renal cell carcinoma treated with everolimus: a meta- analysis of phase 3 randomized controlled trials. Henry P. Igid, Kyaw Z. Thein, Sriman Swarup, Anita Sultan, Fred Hardwicke, Nicholas D’Cunha, Lukman Tijani. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e16553. 

  • 05/2018: Risk of health-related quality of life and metabolic events and pulmonary toxicities in patients with advanced renal cell carcinoma treated with everolimus: a meta- analysis of phase 3 randomized controlled trials. Rachana Yendala, Kyaw Z. Thein, Sriman Swarup, Anita Sultan, Nicholas D’Cunha, Sanjay Awasthi, Lukman Tijani. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e16551. 

     

     

  • 05/2018: Incidence of pneumonitis in patients with solid tumors treated with everolimus: a systematic review and meta- analysis of randomized controlled trials. Kyaw Z. Thein, Anita Sultan, Sriman Swarup, Fred Hardwicke, Catherine Jones, Lukman Tijani, Sanjay Awasthi, Nicholas D’Cunha. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e22220.

  • 05/2018: Incidence and risks of pneumonia in patients with multiple myeloma treated with daratumumab: A systematic review and meta-analysis of randomized controlled trials. Aung M. Tun, Katy Ticona, Kyaw Z. Thein, Poras Patel, Vadim Zarubin, Elizabeth Guevara. 2018 ASCO Annual Meeting. Journal of Clinical Oncology 36, no. 15_suppl. DOI: 10.1200/JCO.2018.36.15_suppl.e20021.

  • 03/2018: Incidence and risk of hand foot syndrome (HFS) in patients with cancer treated with regorafenib. Miguel Quirch, Kyaw Z. Thein, Anita Sultan, Sriman Swarup, Somedeb Ball, Lukman Tijani, Catherine Jones, Fred Hardwicke. Student Research Week (SRW), TTUHSC.

  • 03/2018 A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of pulmonary toxicities in patients with chronic lymphocytic leukemia treated with idelalisib. Kyaw Z. Thein, Ei M. Phyu, Myint A. Win, Nicholas D’Cunha, Donald Quick, Kenneth Pendergrast, Lukman Tijani. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018 J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 Risk of gastrointestinal and hepatic toxicities in patients with chronic lymphocytic leukemia treated with idelalisib: A systematic review and meta-analysis of randomized controlled trials. Kyaw Z. Thein, Myint A. Win, Ei M. Phyu, Nicholas D’Cunha, Mark Currie, Lukman Tijani, Donald Quick. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 Risk of health-related quality of life events from fatigue, anorexia, pyrexia, electrolyte imbalance and dermatological toxicities in patients with chronic lymphocytic leukemia treated with idelalisib. Ei M. Phyu, Kyaw Z. Thein, Myint A. Win, Lukman Tijani, Donald Quick, Prospero Cortorreal, Nicholas D’Cunha. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of hematological toxicities in patients with chronic lymphocytic leukemia treated with idelalisib. Myint A. Win, Kyaw Z. Thein, Ei M. Phyu, Nicholas D’Cunha, Lukman Tijani, Edward Arsura, Donald Quick. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of gastrointestinal and hepatic toxicities in patients with cancer treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors. Kyaw Z. Thein, Myat M. Han, Myo H. Zaw, Fred Hardwicke, Saba Radhi, Sanjay Awasthi, Catherine Jones. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 Risk of fatigue and hematological toxicities in patients with cancer treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors: A systematic review and meta-analysis of randomized controlled trials. Kyaw Z. Thein, Myo H. Zaw, Myat M. Han, Saba Radhi, Fred Hardwicke, Sanjay Awasthi, Catherine Jones. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of hematological toxicities in patients with myelofibrosis treated with janus kinase (JAK) inhibitors. Kyaw Z. Thein, Myo H. Zaw, Henry P. Igid, Rachana Yendala, Edna Juarez, Donald Quick, Lukman Tijani. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 Risk of hematological toxicities in patients with myeloproliferative neoplasms treated with ruxolitinib: a systematic review and meta-analysis of randomized controlled trials. Kyaw Z. Thein, Henry P. Igid, Rachana Yendala, Myo H. Zaw, Miguel Quirch, Lukman Tijani, Donald Quick. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 03/2018 A systematic review and meta-analysis of lapatinib monotherapy in patients with brain metastases from HER-2 positive metastatic breast cancer. Kyaw Z. Thein, Myo H. Zaw, Rachana Yendala, Henry P. Igid, Chatree Chai-Adisaksopha, Fred Hardwicke, Saba Radhi, Catherine Jones, Sanjay Awasthi. 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2018. J Natl Compr Canc Netw 2018;16: e-1-e-31
  • 12/2017 Serious cardiovascular events and clinical outcomes in secondary polycythemia: Efficacy of conventional phlebotomy and proposed hematocrit target. Ajaz Bulbul, Emilio P. Araujo-Mino, Matney Huber, Adrianna Bautista, Kyaw Z. Thein, Hatim Husain, Flowers Brittany, Sanjay Awasthi, Sai-Ching J. Yeung, Masoud Khorsand. 59th American Society of Hematology (ASH) Annual Meeting and Exposition, 2017. Blood, 130(Suppl 1), 4751, http://www.bloodjournal.org /content/130/ Suppl_1/4751, 12/2017. e-Pub 12/2017
  • 12/2017 Prevalence and prognostic significance of CD5 immunohistochemistry in De-Novo DLBCL in a western population cohort. Ajaz Bulbul, Kyaw Z. Thein, Emilio P. Araujo-Mino, Sai-Ching J. Yeung, Denice Tsao-Wei, Matney Huber, Siham Chouial, Sanjay Awasthi, Masoud Khorsand. 59th American Society of Hematology (ASH) Annual Meeting and Exposition, 2017. Blood, 130(Suppl 1), 5218, http://www.bloodjournal.org /content/130/ Suppl_1/5218, 12/2017. e-Pub 12/2017
  • 12/2017 Vitamin B12 Deficiency-Related Pseudo-Thrombotic Microangiopathy Might be Misdiagnosed and Treated with Plasma Product Therapy: Review of the Literature and Analysis of the Reported Cases. Aung M. Tun, Zin W. Myint, Cristhium M Rojas-Hernandez, Kyaw Z. Thein, Thein H. Oo59th American Society of Hematology (ASH) Annual Meeting and Exposition, 2017. Blood, 130(Suppl 1), 5576, http://www.bloodjournal.org /content/130/ Suppl_1/5576, 12/2017. e-Pub 12/2017
  • 12/2017 Efficacy of lapatinib and capecitabine combination therapy in brain metastases from HER-2 positive metastatic breast cancer: A systematic review and meta-analysis. Kyaw Z. Thein, Myo H. Zaw, Rachana Yendala, Henry P. Igid, Chatree Chai-Adisaksopha, Fred Hardwicke, Sanjay Awasthi, Saba Radhi. 40th San Antonio Breast Cancer Symposium, 2017. Cancer Research Volume 78, Issue 4 Supplement, pp. P1-17-08. DOI: 10.1158/1538-7445.SABCS17-P1-17-08
  • 12/2017 Incidence of venous thromboembolism in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials. Kyaw Z. Thein, Myo H. Zaw, Aung M. Tun, Catherine Jones, Saba Radhi, Fred Hardwicke, Thein H. Oo. 40th San Antonio Breast Cancer Symposium, 2017. Cancer Research Volume 78, Issue 4 Supplement, pp. P3-14-02. DOI: 10.1158/1538-7445.SABCS17-P3-14-02
  • 10/2017 A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of fatigue and pain among patients treated with ibrutinib. Myo H. Zaw, Kyaw Z. Thein, Myat M. Han, Ruth D’Cunha, Hassan Kaleem, Fred L. Hardwicke, Lukman Tijani. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 213-213. DOI: 10.1200/JCO.2017.35.31_suppl.213
  • 10/2017 Risk of health-related quality of life events from pain and fatigue among patients with hormone receptor-positive HER-2 negative metastatic breast cancer treated with CDK 4/6 inhibitor. Myat M. Han, Kyaw Z. Thein, Myo H. Zaw, Aung Tun, Paul D’Cunha, Fred L. Hardwicke, Catherine Jones. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 215-215. DOI: 10.1200/JCO.2017.35.31_suppl.215
  • 10/2017 A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of fatigue and pain among patients with metastatic solid tumors treated with cabozantinib. Myat M. Han, Kyaw Z. Thein, Myo H. Zaw, Luke D’Cunha, Abhilash Perisetti, Fred L. Hardwicke, Lukman Tijani. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 214-214. DOI: 10.1200/JCO.2017.35.31_suppl.214
  • 10/2017 Incidence of palmar-plantar erythrodysesthesia and hypothyroidism in patients with metastatic cancer treated with cabozantinib: A systematic review and meta-analysis of randomized controlled trials. Kyaw Z. Thein, Myo H. Zaw, Myat M. Han, Jirapat Teerakanok, Catherine Jones, Lukman Tijani, Fred L. Hardwicke. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 204-204. DOI: 10.1200/JCO.2017.35.31_suppl.204
  • 10/2017 Risk of hematological toxicities and febrile neutropenia in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials. Myo H. Zaw, Kyaw Z. Thein, Aung M. Tun, Myat M. Han, Saba Radhi, Fred L. Hardwicke, Catherine Jones. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 207-207. DOI: 10.1200/JCO.2017.35.31_suppl.207
  • 10/2017 Risk of gastrointestinal and hepatic toxicities in patients with metastatic solid tumors treated with cabozantinib: A systematic review and meta- analysis of randomized controlled trials. Myo H. Zaw, Kyaw Z. Thein, Myat M. Han, Henry P. Igid, Fred L. Hardwicke, Lukman Tijani. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 208-208. DOI: 10.1200/JCO.2017.35.31_suppl.208
  • 10/2017 A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of gastrointestinal and hepatic toxicities in patients with hormone receptor-positive HER2-negative breast cancer treated with CDK 4/6 inhibitors. Myo H. Zaw, Kyaw Z. Thein, Aung M. Tun, Myat M. Han, Yu Y. Thar, Asha Nayak, Elizabeth Guevara. ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017. Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 209-209. DOI: 10.1200/JCO.2017.35.31_suppl.209
  • 06/2017 A novel function of SMC1 as a transporter of xenobiotics. Rachana Yendala, Lukman Tijani, Kyaw Zin Thein, Henry Palangdao Igid, Mohamed Shanshal, Sanjay Awasthi, Fred L. Hardwicke. 2017 ASCO Annual Meeting. Journal of Clinical Oncology 35, no. 15. DOI: 10.1200/JCO.2017.35.15_suppl.e14107
  • 06/2017 Risk of infectious, hematological, and gastrointestinal side effects in patients treated with ibrutinib: A systematic review and meta-analysis of randomized controlled trials. Myo H. Zaw, Kyaw Z. Thein, Aung M. Tun, Lukman Tijani, Elizabeth Guevara. 2017 ASCO Annual Meeting. Journal of Clinical Oncology 35, no. 15. DOI: 10.1200/JCO.2017.35.15_suppl.e18265
  • 06/2017  Risk of gastrointestinal and hepatic toxicities in patients with hormone receptor-positive HER2-negative breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta- analysis of randomized controlled trials. Aung Myint Tun, Kyaw Zin Thein, Yu Yu Thar, Asha Nayak, Elizabeth Guevara. 2017 ASCO Annual Meeting. Journal of Clinical Oncology 35, no. 15. DOI: 10.1200/JCO.2017.35.15_suppl.e18284
  • 03/2017 Side Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center. Myint A. Win, Kyaw Z. Thein, Aiham Qdaisat, Myat M. Han, Sai-Ching J. Yeung. NCCN 22nd Annual Conference 2017: Improving the Quality, Effectiveness, and Efficiency of Cancer Care. J Natl Compr Canc Netw 2017; 15: 657-670
  • 02/2017 A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Low- Molecular Weight Heparins Versus Oral Vitamin K Antagonists in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism. Kyaw Zin Thein, Lukman Tijani, Thein Hlaing Oo. Student Research Week (SRW), Texas Tech University Health Sciences Center
  • 12/2016 Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs). Kyaw Zin Thein, Lukman Tijani, Thein Hlaing Oo. 58th American Society of Hematology (ASH) Annual Meeting and Exposition. Blood 128(22):1180, http://www.bloodjournal.org/content/128/22/1180, 11/2016. e-Pub 11/2016
  • 12/2016 Risk of Bleeding from Primary Thromboprophylaxis (PTP) in Patients with Solid Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT). Kyaw Zin Thein, Aung Myint Tun, Sai-Ching J Yeung, Thein Hlaing Oo. 58th American Society of Hematology (ASH) Annual Meeting and Exposition. Blood 128(22):3820, http://www.bloodjournal.org/content/128/22/3820, 11/2016. e-Pub 11/2016
  • 12/2016 A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) in Ambulatory Thromboprophylaxis (ATP) in Patients with Lung Cancer Receiving Chemotherapy. Kyaw Zin Thein, Sai-Ching J Yeung, Thein Hlaing Oo. 58th American Society of Hematology (ASH) Annual Meeting and Exposition. Blood 128(22):3825, http://www.bloodjournal.org/content/128/22/38225, 12/2016. e-Pub 11/2016
  • 09/2016 Association between Abdominal Adiposity, Muscle Mass, and Metabolic Syndrome in Survivors of Testicular Germ Cell Cancer. Kyaw Zin Thein, William Osai, Shi-Ming Tu, Lance C. Pagliaro, Jeri Kim, Sai-Ching J. Yeung. American Society of Clinical Oncology (ASCO) 2016 palliative care in oncology symposium. Journal of Clinical Oncology 34(26_suppl):250-250, October 2016. DOI: 10.1200/jco.2016.34.26_suppl.250. Peer Reviewed Journal Articles (Published):
  • 06/2018 Copper Deficiency Anemia: Review Article. Zin W. Myint, Thein H. Oo, Kyaw Z. Thein, Aung M. Tun, Hayder Saeed Annals of Hematology 2018 Jun 29. DOI: 10.1007/s00277-018-3407-5
  • 05/2018 Adverse Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center. Imad El Majzoub, Aiham Qdaisat, Kyaw Z. Thein, Myint A. Win, Myat M. Han, Kalen Jacobson, Patrick S. Chaftari, Michael Prejean, Cielito Reyes-Gibby, Sai-Ching J Yeung. Annals of Emergency Medicine. DOI: 10.1016/j.annemergmed.2018.04.019
  • 03/2018 Mushroom Poisoning Mimicking Painless Progressive Jaundice: A Case Report with Review of the Literature. Abhilash Perisetti, Saikiran Raghavapuram, Abu Baker Sheikh, Rachana Yendala, Rubayat Rahman, Mohamed Shanshal, Kyaw Thein, Asif Farooq. Cureus 10(4): e2436. DOI 10.7759/cureus.2436
  • 02/2018 Mechanisms of thrombogenesis in Philadelphia negative classical Myeloproliferative neoplasms: A comprehensive Review. Somedeb Ball, Kyaw Z. Thein, Abhishek Maiti, Kenneth Nugent. J Thromb Thrombolysis Feb 2018 DOI: 10.1007/s11239-018-1623-4
  • 09/2017 Primary Thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta- analysis of randomized controlled trials (RCTs). Kyaw Zin Thein, Sai-Ching Jim Yeung, Thein Hlaing Oo. Asia-Pacific Journal of Clinical Oncology Sep 26 2017 DOI:10.1111/ajco.12770
  • 08/2017 A Rare Case of Primary Esophageal Diffuse Large B Cell Lymphoma Presenting with Tracheoesophageal Fistula and Review. Jirapat Teerakanok, Judy Park DeWitt, Edna Juarez, Kyaw Zin Thein, Irfan Warraich. World Journal of Gastrointestinal Oncology 2017 Oct 15;9(10):431-435 doi: 10.4251/wjgo.v9.i10.431
  • 02/2017 Acute Symptomatic Hypocalcemia from Immune Checkpoint Therapy-Induced Hypoparathyroidism. Myint A. Win, Kyaw Z. Thein, Aiham Qdaisat, Sai-Ching J. Yeung. The American journal of emergency medicine, February 2017. DOI: 10.1016/j.ajem.2017.02.048
  • 02/2017 Pernicious Anemia: Fundamental and Practical Aspects in Diagnosis. Aung Myint Tun, Kyaw Zin Thein, Zin War Myint, Thein Hlaing Oo. Cardiovascular & hematological agents in medicinal chemistry. DOI: 10.2174/1871525715666170203114632
  • 10/2016 Cancer Immunotherapy-induced Posterior Reversible Encephalopathy Syndrome in an Emergency Department. Myint A. Win, Kyaw Z. Thein, Sai-Ching J. Yeung. The American journal of emergency medicine 35(4), October 2016. DOI: 10.1016/j.ajem.2016.10.069
  • Risk of hematological toxicities in patients with myeloproliferative neoplasms treated with ruxolitinib: a systematic review and meta-analysis of randomized controlled trials. Kyaw Z. Thein, Henry P. Igid, Rachana Yendala, Myo H. Zaw, Miguel Quirch, Lukman Tijani, Donald Quick. Submitted to 23rd NCCN Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, 2017
  • Efficacy of lapatinib and capecitabine combination therapy in brain metastases from HER-2 positive metastatic breast cancer: A systematic review and meta-analysis. Kyaw Z. Thein, Myo H. Zaw, Rachana Yendala, Henry P. Igid, Chatree Chai-Adisaksopha, Fred Hardwicke, Sanjay Awasthi, Saba Radhi. Accepted to 40th San Antonio Breast Cancer Symposium, 2017
  • Risk of health-related quality of life events from pain and fatigue among patients with hormone receptor-positive HER-2 negative metastatic breast cancer treated with CDK 4/6 inhibitor. Myat M. Han, Kyaw Z. Thein, Myo H. Zaw, Aung Tun, Paul D’Cunha, Fred L. Hardwicke, Catherine Jones. Accepted to ASCO Palliative and Supportive Care in Oncology Symposium: Patient-centered Care across the Cancer Continuum, 2017
  • A novel function of SMC1 as a transporter of xenobiotics. Rachana Yendala, Lukman Tijani, Kyaw Zin Thein, Henry Palangdao Igid, Mohamed Shanshal, Sanjay Awasthi, Fred L. Hardwicke. 2017 ASCO Annual Meeting. DOI: 10.1200/JCO.2017.35.15_suppl.e14107 Journal of Clinical Oncology 35, no. 15
  • Risk of infectious, hematological, and gastrointestinal side effects in patients treated with ibrutinib: A systematic review and meta-analysis of randomized controlled trials. Myo H. Zaw, Kyaw Z. Thein, Aung M. Tun, Lukman Tijani, Elizabeth Guevara. 2017 ASCO Annual Meeting. DOI: 10.1200/JCO.2017.35.15_suppl.e18265 Journal of Clinical Oncology 35, no. 15
  • Risk of gastrointestinal and hepatic toxicities in patients with hormone receptor-positive HER2-negative breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta- analysis of randomized controlled trials Aung Myint Tun, Kyaw Zin Thein, Yu Yu Thar, Asha Nayak, Elizabeth Guevara. 2017 ASCO Annual Meeting. DOI: 10.1200/JCO.2017.35.15_suppl.e18284 Journal of Clinical Oncology 35, no. 15
  • Side Effects of Immune Checkpoint Therapy in Cancer Patients Visiting the Emergency Department of a Comprehensive Cancer Center Myint A. Win, Kyaw Z. Thein, Aiham Qdaisat, Myat M. Han, Sai-Ching J. Yeung NCCN 22nd Annual Conference 2017: Improving the Quality, Effectiveness, and Efficiency of Cancer Care
  • Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs) Kyaw Zin Thein, Lukman Tijani, Thein Hlaing Oo 58th American Society of Hematology (ASH) Annual Meeting and Exposition Blood 128(22):1180, http://www.bloodjournal.org/content/128/22/1180, 11/2016. e-Pub 11/2016.
  • Risk of Bleeding from Primary Thromboprophylaxis (PTP) in Patients with Solid Cancer Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) Kyaw Zin Thein, Aung Myint Tun, Sai-Ching J Yeung, Thein Hlaing Oo 58th American Society of Hematology (ASH) Annual Meeting and Exposition Blood 128(22):3820, http://www.bloodjournal.org/content/128/22/3820, 11/2016. e-Pub 11/2016.
  • A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCT) in Ambulatory Thromboprophylaxis (ATP) in Patients with Lung Cancer Receiving Chemotherapy Kyaw Zin Thein, Sai-Ching J Yeung, Thein Hlaing Oo 58th American Society of Hematology (ASH) Annual Meeting and Exposition Blood 128(22):3825, http://www.bloodjournal.org/content/128/22/38225, 12/2016. e-Pub 11/2016.
  • Association between Abdominal Adiposity, Muscle Mass, and Metabolic Syndrome in Survivors of Testicular Germ Cell Cancer Kyaw Zin Thein, William Osai, Shi-Ming Tu, Lance C. Pagliaro, Jeri Kim, Sai-Ching J. Yeung American Society of Clinical Oncology (ASCO) 2016 palliative care in oncology symposium Journal of Clinical Oncology 34(26_suppl):250-250, October 2016 DOI: 10.1200/jco.2016.34.26_suppl.250
  • Primary Thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta- analysis of randomized controlled trials (RCTs) Kyaw Zin Thein, Sai-Ching Jim Yeung, Thein Hlaing Oo Accepted to Asia-Pacific Journal of Clinical Oncology DOI:10.1111/ajco.12770
  • A Rare Case of Primary Esophageal Diffuse Large B Cell Lymphoma Presenting with Tracheoesophageal Fistula and Review Jirapat Teerakanok, Judy Park DeWitt, Edna Juarez, Kyaw Zin Thein, Irfan Warraich Accepted to World Journal of Gastrointestinal Oncology
    Acute Symptomatic Hypocalcemia from Immune Checkpoint Therapy-Induced Hypoparathyroidism Myint A. Win, Kyaw Z. Thein, Aiham Qdaisat, Sai-Ching J. Yeung The American journal of emergency medicine, February 2017 DOI: 10.1016/j.ajem.2017.02.048
    Pernicious Anemia: Fundamental and Practical Aspects in Diagnosis Aung Myint Tun, Kyaw Zin Thein, Zin War Myint, Thein Hlaing Oo Cardiovascular & hematological agents in medicinal chemistry DOI: 10.2174/1871525715666170203114632
  • Cancer Immunotherapy-induced Posterior Reversible Encephalopathy Syndrome in an Emergency Department Myint A. Win, Kyaw Z. Thein, Sai-Ching J. Yeung The American journal of emergency medicine 35(4), October 2016 DOI: 10.1016/j.ajem.2016.10.069
  • Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy. Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M. Int Rev Immunol. 2015 Mar;34(2): 154-87 doi: PMID 25901860
  • Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection. Lu C, Figueroa JA, Liu Z, Konala V, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W. Curr Cancer Drug Targets. 2015 PMID: 26324128
  • Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine. Soape MP, Verma R, Payne JD, Wachtel M, Hardwicke F, Cobos E. Case rep Gastrointest Med. 2015. Epub 2015 Jun 17. PMID 26167310
  • Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium. Mirandola L, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, Cobos E, Jenkins MR, Chiriva-Internati M. Int Rev Immunol. 2015 Mar;34(2):134-42. doi: PMID 25901858
  • The role of human papilloma virus (HPV) infection in non-anogential cancer and the promise of immunotherapy Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, Aulakh A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman RL, Pandey A, Radhi S, Nguyen DD, Jenkins M, Chiriva-Internati M, Cobos E. Int Rev Immunol. 2014 Oct;33(5):383-401. doi:Epub 2014 May 8. PMID 24811210